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a  b  s  t  r  a  c  t
Background  and  objective:  To  clarify  the clinical  features  of  coronary  artery  spasm  (CAS)  with  no  signiﬁcant
coronary  stenosis  in patients  with  suspected  acute  coronary  syndrome  (ACS)  in real  practice.
Methods:  This  is  a retrospective  observational  study  of  patients  with  suspected  ACS  (n  = 645)  based  on
symptoms,  electrocardiographic  changes,  and/or  positive  cardiac  biomarkers  and  vasospastic  angina
(VSA,  n = 90).  ACS  patients  were  divided  into  two  groups:  (1)  organic  ACS  (n =  515),  culprit  lesion  ≥75%
coronary  stenosis  with/without  thrombosis;  (2) spastic  ACS  (n =  70),  coronary  stenosis  <75%,  either  with
positive  acetylcholine  (ACh)  test  (n =  51)  or without  ACh  test  but  veriﬁed  spontaneous  spasm  (n =  19).  The
study  compared  clinical  characteristics  among  organic  ACS,  spastic  ACS,  and VSA.
Results:  One  hundred  and  thirty  suspected  ACS  patients  had  a coronary  organic  stenosis  <75% (130/645,
20%).  Seventy  of those  patients  (70/130,  54%)  were  conﬁrmed  to have  CAS,  and these  accounted  for  11%
of  all  ACS  patients  (70/645).  The  rate  of cigarette  smoking  was highest  in  the  spastic  ACS. No  spastic  ACS
patients  died  during  their  hospital  stay  or after  discharge,  whereas  acute  myocardial  infarction  occurred
in 19%,  aborted  sudden  cardiac  death  in  6%,  multivessel  spasm  was  provoked  in  78%,  and  diffuse  spasm
was  more  frequently  provoked  than  in the VSA  group  (82%  vs. 62%).
Conclusions:  CAS  is  not  a rare cause  of  ACS.  Although  the prognosis  of  spastic  ACS  is  good,  there  are
occasional  critical  cases.  An  initial  differential  diagnosis  including  an ACh  test  is thus  important  to  decide
the  treatment  strategy  of  ACS.
© 2013  Japanese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.ntroduction
The most common cause of acute coronary syndrome (ACS) is
hrombotic occlusion triggered by a ruptured vulnerable plaque
n patients with coronary atherosclerosis [1,2]. On the other hand,
oronary artery spasm (CAS) is recognized as another important
echanism involved in the pathogenesis of ACS since more than 30
ears ago [3–5]. Spasm provocation test using acetylcholine (ACh)
r ergonovine has been established as the standard method to ver-
fy CAS [6,7]. Several studies attempted to clarify the prevalence
nd clinical characteristics of CAS in various disease conditions,
uch as overall coronary artery diseases [8], variant angina [9], or
asospastic angina (VSA) [10], acute myocardial infarction (AMI)
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914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.12.008or recent MI  [11,12], ACS [13,14], and acute or chronic chest pain
syndrome [15,16]. CAS is not uncommon and plays an important
role in these disease conditions [17,18]. Racial differences in the
prevalence of CAS have also been reported, showing that Japanese
patients are prone to be hyperresponsive to ACh after AMI  in com-
parison to Caucasian patients [12,19]. Patients with positive CAS
after AMI  have a poorer prognosis than those with negative CAS
[20]. Cigarette smoking is the most common predisposing risk fac-
tor for the prevalence and poor prognosis of variant angina/VSA
[21,22].
Although the clinical importance of CAS in coronary artery
disease is recognized, various issues are still unclear: (1) the preva-
lence of CAS in ACS at the ﬁrst appearance in a hospital; (2) impact
of coronary risk factors, especially cigarette smoking, on spasm-
induced ACS in comparison to VSA; (3) differences in coronary
responsiveness to ACh between spasm-induced ACS and VSA. An
observational study focusing on the clinical features of CAS with no
signiﬁcant coronary stenosis in patients with suspected ACS was
conducted to clarify these issues.
vier Ltd. All rights reserved.






















































Fig. 1. Disposition ﬂowchart of suspected ACS patients. The following two groups
were analyzed in the present study. (1) Organic ACS (n = 515): culprit coronary steno-
sis ≥75% and/or thrombotic obstruction; (2) spastic ACS (n = 70): coronary stenosis
<75% with positive ACh test (n = 51), and organic coronary stenosis <75% without ACh
test but spontaneous and transient ST elevation on ECG, or spontaneous spasm on
control CAG was documented (n = 19). ACS, acute coronary syndrome; ACh, acetyl-S. Satoh et al. / Journal of 
ethods
atient population
This is a retrospective observational study in patients who
nderwent selective coronary angiography (CAG) because of sus-
ected ACS or diagnosis of VSA from March 2006 to July 2010,
xtracted from the institutional data base based on the following
linical ﬁndings:
atients with suspected ACS
The latest guidelines of American College of Cardiol-
gy/American Heart Association [23] were used to select patients
hat presented with acute ischemic symptoms lasting ≥30 min  and
schemic electrocardiogram (ECG) changes, and/or positive cardiac
iomarkers (troponin-T and/or creatine kinase-MB). Ischemic
CG changes were deﬁned as transient ST-segment elevation or
epression, and newly appeared negative U waves. Sixty-ﬁve of
30 patients did not undergo CAG because of conditions unsuitable
or cardiac catheterization, such as extremely high-age, marked
enal dysfunction, and poor general conditions. Twenty of the
emaining 665 patients who underwent selective CAG within 3
ays after admission (average 1.2 days) were excluded due to
rior coronary artery bypass grafting (CABG). Finally a total of 645
atients were included for further analysis. Quantitative CAG was
ssessed by visual estimation.
Patients with culprit lesion ≥75% coronary stenosis and/or
ccompanied with thrombotic obstruction were deﬁned as the
oronary stenosis-based group (organic ACS, n = 515). These
atients thereafter underwent primary/elective percutaneous
oronary intervention, CABG, or conservative medical therapy.
The patients with coronary organic stenosis <75% (n = 130) were
lassiﬁed into 4 subgroups: (1) positive ACh test; coronary organic
tenosis <75% with positive ACh test (n = 51); (2) coronary organic
tenosis <75% without ACh test but veriﬁed spontaneous spasm
spontaneous and transient ST elevation on ECG that was  quickly
elieved by one tablet of sublingual nitroglycerin, or spontaneous
pasm was veriﬁed on control CAG, n = 19); (3) negative ACh test
n = 18); and (4) no ACh test due to the decision of attending physi-
ians (n = 42). Both (1) and (2) were deﬁned as the spasm positive
roup (spastic ACS, n = 70).
Fig. 1 shows the disposition ﬂowchart of suspected ACS patients.
atients with suspected VSA
Patients that presented with repeated ischemic symptoms
ainly at rest, especially between night and early morning over
he previous year (n = 90). Symptoms had been relieved within
–10 min  or quickly by one tablet of sublingual nitroglycerin. An
xercise stress test by ECG was either positive or negative, and 83
f 90 patients showed negative responses.
pasm provocation test
A spasm provocation test using ACh was performed when selec-
ive CAG revealed a coronary stenosis <75% and CAS was suspected
s a cause of symptoms, with the support of temporary right ven-
ricular pacing under vasodilator-free conditions according to the
uidelines indicated by the Japanese Circulation Society [7]. Con-
inuous infusion of isosorbide dinitrate, nitroglycerin, or nicorandil
as discontinued 3 h before cardiac catheterization in ACS patients
hose symptoms and ECG changes had been relieved by 1–2 tablets
f nitroglycerin on admission. Coronary vasodilating agents, such
s calcium-channel blockers, isosorbide dinitrate, and nicorandil,
ere discontinued 48 h before cardiac catheterization in patients
ith suspected VSA. ACh was selectively injected in incremental
oses of 50 and 100 g into the left coronary artery (LCA) ﬁrst,choline; ECG, electrocardiogram; CAG, coronary angiography; CABG, coronary artery
bypass graft.
and then 25 and 50 g into the right coronary artery (RCA) within
15 s. Documentation of ECG, symptoms, and CAG was performed
60 s after the administration of ACh. Intracoronary administration
of 1–2 mg  isosorbide dinitrate was given when a severe spasm was
provoked in the LCA and it was  not relieved within 5 min  associated
with prolonged chest pain and ischemic ECG changes, and thus no
ACh was injected into the RCA. Patients with microvessel spasm
were excluded from the present study.
A positive ACh test was deﬁned as: transient total or sub-total
occlusion (≥90% stenosis in comparison to the maximal diame-
ter after the intracoronary administration of 1–2 mg  isosorbide
dinitrate) accompanied by ischemic symptoms and ECG changes.
Patients that showed a spontaneous attack with transient ST eleva-
tion on ECG that was quickly relieved by sublingual nitroglycerin,
or control CAG revealed spontaneous luminal reduction ≥90%
accompanied by ischemic symptoms and ECG changes were also
diagnosed as CAS without an ACh test. Focal spasm was deﬁned as
total occlusion without distal ﬁlling or focal subocclusion involv-
ing <70% of the segment (vessel from a side branch to the next
branch) length with normal or near-normal distal caliber, and seg-
mental spasm was  deﬁned as subtotal occlusion involving ≥70% of
the segment length as deﬁned previously by Pristipino et al. [12].
Diffuse spasm was deﬁned as subtotal occlusion involving ≥2 con-
secutive segments. Representative angiograms are shown in Fig. 2.
Multivessel spasm was  deﬁned as spasm occurring simultaneously
in ≥2 vessels of the RCA, left anterior descending (LAD), and left
circumﬂex (LCX) arteries at each ACh dose as deﬁned previously
(that is, a combination of RCA and LAD, RCA and LCX, or LAD and
LCX) [10,12].
Blood tests were performed on admission under casual con-
ditions and/or after admission serially by necessity. Dyslipidemia
was deﬁned as low-density lipoprotein (LDL) cholesterol lev-
els ≥140 mg/dL, high-density lipoprotein (HDL) cholesterol levels
<40 mg/dL, and triglycerides levels ≥150 mg/dL.
Written informed consent for cardiac catheterization and data
utilization was  obtained from each patient, and this study proto-
col conforms to the ethical guidelines of the 1975 Declaration of
Helsinki as reﬂected in a priori approval by this institution’s human
research committee.
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Fig. 2. Representative coronary angiograms of the left coronary artery in acetylcholine (Ach) test. Upper photographs, 1 min  after the administration of intracoronary ACh

























I100  g). (a) Focal spasm. (c) Segmental spasm. (e) Diffuse spasm. Spasm portion
ntracoronary isosorbide dinitrate to obtain the maximal coronary dilatation. Paired
tatistical analysis
Continuous variables are expressed as the mean ± SD. Com-
arisons of continuous variables were performed by the
ann–Whitney test between two groups and the Kruskal–Wallis
est followed by Dunn’s posttest among the three groups, respec-
ively. The chi-square test was used to compare categorical
ariables. A two-tailed p-value <0.05 was considered to be statis-
ically signiﬁcant. All statistical analyses were performed with the
raphPad Prism® 5.0 software package (GraphPad Software, Inc.,
an Diego, CA, USA).
esults
omparison of the clinical background among organic ACS, spastic
CS, and VSA
Fig. 1 shows the disposition of ACS patients. Five hundred and ﬁf-
een of 645 ACS patients (515/645, 80%) had a culprit lesion ≥75%, so
hey developed ACS mainly due to signiﬁcant coronary atheroscle-
osis. On the other hand, 130 patients (130/645, 20%) had a coronary
esion <75%. Seventy of these patients (70/130, 54%) were veriﬁed
s CAS, so that they developed ACS mainly due to CAS. Therefore,
0 of 645 patients (70/645, 11%) had spastic ACS.
Comparisons of the clinical characteristics on admission are
ummarized in Table 1. Both spastic ACS and VSA patients were
ounger than organic ACS patients. Men  were more predominant
n both organic and spastic ACS patients than in VSA patients. The
revalence of hypertension, dyslipidemia, and diabetes mellitus
as lower in spastic ACS patients than in organic ACS patients.
n particular, the prevalence of cigarette smoking was highest inindicated by white arrows. Lower photographs, 2 min  after the administration of
ograms are: a–b, c–d, and e–f, respectively.
spastic ACS patients. The frequency of ST-segment elevation on
admission and the occurrence of AMI  were lower in spastic ACS
patients than in organic ACS patients, and none of the spastic
ACS patients died during their hospital stay or after discharge.
However, the prevalence of aborted sudden cardiac death induced
by ventricular tachycardia/ventricular ﬁbrillation before arrival to
hospital was higher in spastic ACS patients than in organic ACS
patients.
Comparison of biochemical proﬁles among organic ACS, spastic
ACS, and VSA
Comparisons of biochemical characteristics on admission are
summarized in Table 2. Serum LDL cholesterol levels were simi-
lar among the three groups whereas HDL cholesterol levels were
higher in both spastic ACS and VSA patients than in organic ACS
patients. Therefore, the ratios of LDL to HDL were lower in both
spastic ACS and VSA patients than in organic ACS patients. Similarly,
the levels of plasma casual blood sugar and serum hemoglobinA1c
were lower in both spastic ACS and VSA patients than in organic
ACS patients. Evaluation of chronic kidney disease (CKD) by esti-
mated glomerular ﬁltration rate (eGFR) [24] showed that eGFR was
higher in both spastic ACS and VSA patients than in organic ACS
patients.
Comparison of coronary responsiveness to ACh between spastic
ACS and VSAAn ACh test could be performed in both the RCA and LCA in
51 patients with spastic ACS (51/70, 73%) and 87 patients with
VSA (87/90, 97%), respectively. Table 3 shows the comparisons
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Table  1
Comparison of demographic and clinical characteristics of patients with ACS and VSA.
Organic ACS Spastic ACS VSA Total p
Prevalence, n (%) 515/645 (80) 70/645 (11)* 90 <0.0001*
Age, years (mean ± SD) 69 ± 12 63 ± 13¶ 63 ± 11$ <0.0001
Men,  n (%) 367 (71) 51 (73) 52 (58)† ,‡ 0.0306
Risk  factors
Hypertension, n (%) 361 (70) 38 (54)* 47 (52)† 0.0004
Dyslipidemia, n (%) 302 (59) 28 (40)* 47 (52) 0.0099
Diabetes mellitus, n (%) 195 (38) 15 (21)* 24 (27) 0.0058
Smoking, n (%) 198 (38) 36 (51)*,‡ 28 (31) 0.0307
ST  elevation on admission, n (%) 299/515 (58) 29/70 (41) 0.0101*
AMI  (STEMI/non-STEMI), n (%) 318/515 (62) 13/70 (19) <0.0001*
In-hospital mortality, n (%) 17/515 (3) 0/70 (0) <0.0001*
Aborted SCD, n (%) 5/515 (1) 4/70 (6) 0.0149*
ACS, acute coronary syndrome; VSA, vasospastic angina; AMI, acute myocardial infarction; STEMI, ST-segment elevation myocardial infarction; SCD, sudden cardiac death.
* Statistical signiﬁcance between organic ACS and spastic ACS.
† Statistical signiﬁcance between organic ACS and VSA.
‡ Statistical signiﬁcance between spastic ACS and VSA.
¶ Statistical signiﬁcance <0.001 between organic ACS and spastic ACS.
$ Statistical signiﬁcance <0.001 between organic ACS and VSA.
Table 2
Comparison of biochemical proﬁles of patients with ACS and VSA.
Organic ACS Spastic ACS VSA Total p
Total cholesterol, mg/dL 182 ± 38 186 ± 39 199 ± 35† <0.0001
Triglycerides, mg/dL 119 ± 91 118 ± 64 142 ± 87† 0.001
LDL  cholesterol, mg/dL 111 ± 33 108 ± 36 117 ± 31 0.0776
HDL  cholesterol, mg/dL 46 ± 14 54 ± 14* 55 ± 15† <0.0001
LDL/HDL ratio 2.56 ± 0.97 2.16 ± 0.93* 2.23 ± 0.79¶ 0.0003
Casual blood sugar, mg/dL 162 ± 76 128 ± 41* 113 ± 44† <0.0001
HemoglobinA1c, % 6.40 ± 1.20 6.00 ± 0.90‡ 6.07 ± 0.81¶ 0.0026
Creatinine, mg/dL 0.99 ± 0.93 0.78 ± 0.23 0.79 ± 0.57† 0.0002
eGFR,  mL/min/1.73 m2 70 ± 25 79 ± 24‡ 79 ± 20† 0.0001
Max  CRP, mg/dL 1.22 ± 3.26 0.82 ± 3.08 0.16 ± 0.28† <0.0001
Max  creatine kinase, IU/L 408 ± 699 176 ± 162 0.102
ACS, acute coronary syndrome; VSA, vasospastic angina; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular ﬁltration rate; CRP,
C-reactive protein.














A† Statistical signiﬁcance <0.001 between organic ACS and VSA.
‡ Statistical signiﬁcance <0.05 between organic ACS and spastic ACS.
¶ Statistical signiﬁcance <0.05 between organic ACS and VSA.
f coronary contractile response to ACh. Diffuse spasm was  more
requently provoked in spastic ACS patients than in VSA patients
hereas focal-segmental spasm occurred more frequently in VSA
atients. Multivessel spasm was provoked with a similar incidence
etween the two groups.
iagnosis of negative-ACh test patients
Final diagnosis of patients with negative ACh test (n = 18) were
s follows: atypical chest pain, 11; gastroesophageal reﬂux disease,
; gastroduodenal ulcer, 2; paroxysmal supraventricular tachycar-
ia, 1; Tako-tsubo cardiomyopathy [25], 1; cardiac syndrome X,
.
All patients in each group survived 8 months after discharge.
able 3
omparison of the acetylcholine response of coronary artery in patients with coro-
ary artery spasm.
Spastic ACS VSA p
ACh test, n (%) 51/70 (73) 87/90 (97)
Focal-segmental, n (%) 9 (18) 33 (38)*
Diffuse, n (%) 42 (82)* 54 (62) 0.0133
Multivessel, n (%) 40 (78) 63 (72) 0.5263
CS, acute coronary syndrome; VSA, vasospastic angina; ACh, acetylcholine.
* Between spastic ACS and VSA in each response category.Discussion
The present study showed that 20% of cases have no signiﬁ-
cant coronary culprit lesion in patients with suspected ACS at the
ﬁrst appearance. About half of these patients were veriﬁed to have
spasm-induced ACS. Therefore, about 10% of ACS was primarily
caused by CAS. Smoking may  be a more important risk factor for
spasm-induced ACS than for organic ACS and VSA in comparison to
other classic risk factors. Diffuse spasm may  be more inducible in
spasm-induced ACS patients than in VSA patients.
Prevalence of CAS in ACS
Several works have attempted to elucidate the incidence
and clinical characteristics of CAS in various patient populations
including those with overall ischemic heart disease [8], vari-
ant angina/VSA [9,10], acute/recent MI  [11,12], ACS [13,14], and
acute/chronic chest pain syndrome [15,16]. Some studies reported
different results concerning the incidence of CAS and racial dif-
ferences in coronary responsiveness, depending on the patient
population, severity of coronary stenosis, and applied agents for
spasm provocation test (either ergonovine or ACh). Using the
ergonovine test in ACS patients with insigniﬁcant coronary lesions
and/or positive troponin-I/T, Wang et al. [13] found that the inci-
dence of CAS is 41% in Taiwan, and Martínez-Sellés et al. [16]
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n the present study. In addition to race, differences in the agents
nd administration mode (intravenous ergonovine in their studies
s. intracoronary ACh in the present study) may  be one reason for
he difference. Racial differences in coronary responsiveness have
een also reported in MI  patients. Pristipino et al. [12] reported
hat the incidence of CAS veriﬁed by ACh test in Japanese is higher
han in Caucasians (80% vs. 37%), and multivessel spasm is also
ore common (64% vs. 17%) after AMI  including ST-segment ele-
ation myocardial infarction (STEMI) and non-STEMI, where most
atients had signiﬁcant coronary lesions.
A recent prospective study, the CASPAR study [14] like the
resent study, investigated patients with ACS at the ﬁrst appear-
nce at the hospital, and performed the spasm provocation test
sing intracoronary ACh. They reported that 138/488 (28%) patients
ith ACS had no signiﬁcant coronary culprit lesion. Eighty-six of the
16 patients underwent the coronary spasm provocation test and
f those 42 patients (42/86, 49%) had spasm-induced ACS. CAS thus
ccounted for 30% (42/138) of all ACS patients with no signiﬁcant
oronary lesion. The incidence of no signiﬁcant coronary lesion in
CS is similar to that in the present study (28% vs. 20%) whereas that
f CAS in all ACS patients with no signiﬁcant lesion is slightly lower
han that in the present study (30% vs. 54%). These results suggest
hat there are also racial differences in coronary hyperresponsive-
ess in ACS with no signiﬁcant coronary lesion present between
apanese and German patient populations.
mpact of risk factors on CAS-induced ACS
There was no difference in the LDL cholesterol levels between
CS and VSA patients, whereas the HDL cholesterol levels were
ower in the organic ACS than in the other two spastic groups.
he ratio of LDL to HDL was thus higher in organic ACS patients
han in the two spastic groups. These results may  reﬂect a previ-
us report suggesting that a high LDL/HDL ratio is a risk for the
rogression of coronary atherosclerosis [26]. Similarly, control of
iabetes mellitus was better in the spastic patients than in organic
CS patients as assessed by hemoglobinA1c levels. Evaluation of
KD by eGFR [24] as a surrogate marker revealed that the morbid-
ty rate of CKD was lower in spastic patients than in organic ACS
atients. A recent meta-analysis study indicated that low eGFR is
n independent risk factor for cardiovascular mortality [27]. On the
ther hand, the present study showed the prevalence of cigarette
moking was highest in spastic ACS.
These results suggest that classic coronary risk factors [28] other
han cigarette smoking may  not have a greater negative inﬂuence
n spastic coronary disease than on organic ACS. In addition to
revious reports showing that cigarette smoking is the most predis-
osing factor associated with CAS [21,22], the present study further
mphasized that smoking may  be a more signiﬁcant risk factor in
pastic ACS than in VSA.
ifferences in contractility of coronary artery between
AS-induced ACS and VSA
The present study showed that diffuse spasm is more frequently
nducible in spastic ACS patients than in VSA patients, suggesting
hat diffuse hyperresponsiveness of the vessel wall along the entire
oronary artery might underlie spastic ACS. Other unknown factors
ay  underlie in the coronary contractility of CAS patients, since
he incidence of multivessel spasm was similar between the two
roups. Kim et al. [10] compared the contractile response to ACh
n VSA patients with or without AMI. Multivessel spasm (76% vs.
7%) and diffuse spasm (86% vs. 59%) were more frequent in VSA
atients with AMI  than in those without AMI. Differences in thelogy 61 (2013) 404–409
race and study population (MI  vs. ACS) might be one reason for the
discrepancy between the study by Kim et al. and the present study.
Clinical impact and implication of CAS-induced ACS
The present study revealed comprehensive features of coronary
spastic syndrome including spastic ACS and VSA in comparison to
organic ACS. The initial differential diagnosis including an ACh test
is important in the treatment strategy of ACS to decide between
medical therapy and percutaneous coronary intervention because
CAS is not an uncommon cause of ACS with no signiﬁcant coro-
nary stenosis. CAS should be considered as a cause of ACS when
patients show rapid resolution of symptoms and ST-T change by
sublingual nitroglycerin, and cardiac catheterization should be per-
formed under vasodilator-free conditions to conduct an ACh test if
indicated.
No patients with spastic ACS died during their hospital stay
or after discharge, indicating a good prognosis in these patients.
However, about 20% developed AMI, and the incidence of aborted
sudden cardiac death due to ventricular tachycardia/ventricular
ﬁbrillation before arrival to hospital was  higher in spastic ACS
patients than in organic ACS patients. CAS is a critical cause of life-
threatening arrhythmia [29,30]. It thus should be remembered that
serious cases may  occur in spastic ACS as in organic ACS.
Study limitations
First, this study was  a retrospective observational study encom-
passing a selection bias. The ACh test was  not performed when
nitroglycerin had been continuously infused by the attending
physicians’ decision just before cardiac catheterization in most
patients with no ACh test (n = 42). The prevalence of positive CAS
thus could be changed if these patients were included. In addi-
tion, CAS could also trigger ACS in patients with signiﬁcant organic
coronary stenosis. The ACh test was not performed in patients
with a coronary stenosis ≥75%, thus this study could not deter-
mine the precise incidence of CAS in ACS. Second, the prevalence of
multivessel spasm may  be underestimated because some patients
underwent the ACh test only in the LCA. Third, prescribed med-
ications and basic therapies, such as diet and exercise were not
controlled among the three patient groups because this was a ret-
rospective study. This may  have obscured the impact of risk factors
on the studied groups.
Conclusion
CAS is one of the potential causes of ACS. Cigarette smoking may
be a more potent risk factor in spasm-induced ACS than in VSA.
Although the prognosis of spasm-induced ACS is good, critical cases
occasionally occur. An initial differential diagnosis including an ACh
test is thus important in the treatment strategy of ACS in order to
determine whether medical or interventional therapy is indicated.
Conﬂict of interest
None declared.
AcknowledgmentsThe authors are grateful to the technical staffs in the Depart-
ments of Clinical Laboratory, and Radiology, National Hospital























[S. Satoh et al. / Journal of 
eferences
[1] Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coro-
nary artery disease and the acute coronary syndromes (1). N Engl J Med
1992;326:242–50.
[2] Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coro-
nary artery disease and the acute coronary syndromes (2). N Engl J Med
1992;326:310–8.
[3] Maseri A, L’Abbate A, Baroldi G, Chierchia S, Marzilli M,  Ballestra AM,  Severi S,
Parodi O, Biagini A, Distante A, Pesola A. Coronary vasospasm as a possible cause
of  myocardial infarction. A conclusion derived from the study of “preinfarction”
angina. N Engl J Med  1978;299:1271–7.
[4] DeWood M,  Spores J, Notske R, Mouser LT, Burroughs R, Golden MS,  Lamg HT.
Prevalence of total coronary occlusion during the early hours of transmural
myocardial infarction. N Engl J Med  1980;303:897–902.
[5] Yang NI, Hung MJ, Cherng WJ.  Coronary artery spasm-related acute coro-
nary syndrome in patients with coexisting spasm of angiographically normal
coronary artery and ﬁxed narrowing of the remaining vessels. Angiology
2007;58:156–60.
[6] Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G,
Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons
M,  et al. Guidelines on the management of stable angina pectoris: executive
summary: The Task Force on the Management of Stable Angina Pectoris of the
European Society of Cardiology. Eur Heart J 2006;27:1341–81.
[7] Joint JCS. Working Group. Guidelines for diagnosis and treatment of patients
with vasospastic angina (coronary spastic angina). Circ J 2010;74:1745–62.
[8] Bertrand ME,  LaBlanche JM,  Tilmant PY, Thieuleux FA, Delforge MR,  Carre AG,
Asseman P, Berzin B, Libersa C, Laurent JM. Frequency of provoked coronary
artery spasm in 1089 consecutive patients undergoing coronary arteriography.
Circulation 1982;65:1299–306.
[9] Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, Fujii
H,  Morikami Y. Multivessel coronary spasm in patients with variant angina:
a  study with intracoronary injection of acetylcholine. Circulation 1988;77:
535–42.
10] Kim PJ, Seung K-B, Kim D-B, Her S-H, Shin D-I, Jang S-W, Park C-S, Park H-J, Jung
H-O, Baek SH, Kim J-H, Choi K-B. Clinical and angiographical characteristics
of  acute myocardial infarction caused by vasospastic angina without organic
coronary heart disease. Circ J 2007;71:1383–6.
11] Bertrand ME,  Lablanche JM,  Tilmant PY, Thieuleux FA, Delforge MG, Chahine RA.
The provocation of coronary arterial spasm in patients with recent transmural
myocardial infarction. Eur Heart J 1983;4:532–5.
12] Pristipino C, Beltrame JF, Finocchiaro ML,  Hattori R, Fujita M,  Mongiardo R,
Cianﬂone D, Sanna T, Sasayama S, Maseri A. Major racial differences in coronary
constrictor response between Japanese and Caucasians with recent myocardial
infarction. Circulation 2000;101:1102–8.
13] Wang CH, Kuo LT, Hung MJ,  Cherng WJ.  Coronary vasospasm as a possi-
ble cause of elevated cardiac troponin I in patients with acute coronary
syndrome and insigniﬁcant coronary artery disease. Am Heart J 2002;144:
275–81.
14] Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M,  Sechtem U. Coronary
artery spasm as a frequent cause of acute coronary syndrome. The CASPAR
(Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J
Am Coll Cardiol 2008;52:523–7.
15] Coma-Canella I, Castano S, Macías A, Calabuig J, Artaiz M.  Ergonovine test
in  angina with normal coronary arteries. Is it worth doing it? Int J Cardiol
2006;107:200–6.
[logy 61 (2013) 404–409 409
16] Martínez-Sellés M,  Datino T, Pello AM,  Avilés FF. Predictors of coronary spasm
in patients with chest pain and no signiﬁcant coronary stenosis. Int J Cardiol
2010;143:428–30.
17] Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction
in  ischemic heart disease and search for novel therapeutic targets. Circ J
2009;73:394–403.
18] Kawano H, Node K. The role of vascular failure in coronary artery spasm. J
Cardiol 2011;57:2–7.
19] Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vaso-
motor reactivity: differences between Japanese and Caucasian patients. J Am
Coll Cardiol 1999;33:1442–52.
20] Wakabayashi K, Suzuki H, Honda Y, Wakatsuki D, Kawachi K, Ota K, Koba
S,  Shimizu N, Asano F, Sato T, Takeyama Y. Provoked coronary spasm pre-
dicts adverse outcome in patients with acute myocardial infarction: a novel
predictor of prognosis after acute myocardial infarction. J Am Coll Cardiol
2008;52:518–22.
21] Yasue H, Takizawa A, Nagao M,  Nishida S, Horie M, Kubota J, Omote S, Takaoka
K, Okumura K. Long-term prognosis for patients with variant angina and inﬂu-
ential factors. Circulation 1988;78:1–9.
22] Sugiishi M,  Takatsu F. Cigarette smoking is a major risk factor for coronary
spasm. Circulation 1993;87:76–9.
23] Anderson JL, Adams CD, Antman EM,  Bridges CR, Califf RM,  Casey Jr DE, Chavey
2nd  WE,  Fesmire FM,  Hochman JS, Levin TN, Lincoff AM,  Peterson ED, Theroux
P,  Wenger NK, Wright RS, et al. ACC/AHA 2007 guidelines for the management
of patients with unstable angina/non-ST-elevation myocardial infarction. A
Report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to Revise the 2002 Guide-
lines for the Management of Patients With Unstable Angina/Non-ST-elevation
Myocardial Infarction). Circulation 2007;116:803–77.
24] Matsuo S, Imai E, Horio M,  Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino
Y,  Yokoyama H, Hishida A. Collaborators developing the Japanese equation for
estimated GFR. Revised equations for estimated GFR from serum creatinine in
Japan. Am J Kidney Dis 2009;53:982–92.
25] Kurisu S, Kihara Y. Tako-tsubo cardiomyopathy: clinical presentation and
underlying mechanism. J Cardiol 2012;60:429–37.
26] Nicholls SJ, Tuzcu EM,  Sipahi I, Grasso AW,  Schoenhagen P, Hu T, Wolski K,
Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE. Statins, high-density
lipoprotein cholesterol, and regression of coronary atherosclerosis. J Am Med
Assoc 2007;297:499–508.
27] Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M,
Astor BC, Woodward M,  Levey AS, de Jong PE, Coresh J, Gansevoort RT. Associ-
ation of estimated glomerular ﬁltration rate and albuminuria with all-cause
and cardiovascular mortality in general population cohorts: a collaborative
meta-analysis. Lancet 2010;375:2073–81.
28] Itakura H, Nakaya N, Kusunoki T, Shimizu N, Hirai S, Mochizuki S, Ishikawa
T.  Long-term event monitoring study of ﬂuvastatin in Japanese patients with
hypercholesterolemia: efﬁcacy and incidence of cardiac and other events in
elderly patients (≥65 years old). J Cardiol 2011;57:77–88.
29] Hung MJ,  Cheng CW,  Yang NI, Hung MY,  Cherng WJ.  Coronary vasospasm-
induced acute coronary syndrome complicated by life-threatening cardiac
arrhythmias in patients without hemodynamically signiﬁcant coronary artery
disease. Int J Cardiol 2007;117:37–44.
30] Takagi Y, Yasuda S, Takahashi J, Takeda M,  Nakayama M,  Ito K, Hirose M,
Wakayama Y, Fukuda K, Shimokawa H. Importance of dual induction tests for
coronary vasospasm and ventricular ﬁbrillation in patients surviving out-of-
hospital cardiac arrest. Circ J 2009;73:767–9.
